On March 19th, the first implantation of Inovare® transfemoral was performed at Escola Paulista. Conducted by the heart team of the hospital, the procedure was a success.
From now on, a study phase of this new access road for Inovare® Transcatheter Aortic Valve Implantation (TAVI) implants begins. In order for this type of implant to be performed, a new delivery device of high complexity has been developed, which allows even less invasive procedures. The transfemoral implant of TAVI is used in more than 90% of the indicated cases and approval for the Inovare® valve is being processed by ANVISA.